Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]

Detalles Bibliográficos
Autores principales: Lai, Fangfang, Ji, Ming, Huang, Lei, Wang, Yunchen, Xue, Nina, Du, Tingting, Dong, Kai, Yao, Xiaoqing, Jin, Jing, Feng, Zhiqiang, Chen, Xiaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372818/
https://www.ncbi.nlm.nih.gov/pubmed/37521865
http://dx.doi.org/10.1016/j.apsb.2023.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372818/
https://www.ncbi.nlm.nih.gov/pubmed/37521865
http://dx.doi.org/10.1016/j.apsb.2023.05.003

Ejemplares similares